EUVIMEDEUVIMED entdecken
Crossref

Evaluation of CYP2D gene expression in Sahel goats under chronic tramadol exposure

Aliyu Yahaya Gwiokura, Emmanuel O. Adawaren, Yusuf Madaki Lekko, Muhammad Mustapha, Saidu Ibrahim Ngulde

Applied Veterinary Research · 14.10.2026 · 5 (3) · 2026008

DOI: 10.31893/avr.2026008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Veterinary Research, online erschienen am 14.10.2026. Verfasst von Aliyu Yahaya Gwiokura und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tramadol is a widely used opioid analgesic in both human and veterinary medicine, primarily metabolized by the enzyme CYP2D6. While CYP2D6 expression and activity have been well characterized in humans and rodents, limited data exist for ruminants, particularly goats. The objective of the study is to determine the effects of chronic tramadol administration on CYP2D6 gene expression in Sahel goats. In the methodology, six adult goats were divided into three groups (n = 2 animals per group): control, low-dose (4 mg/kg), and high-dose (12 mg/kg) tramadol, administered intramuscularly every 48 hours for 90 days. Post-treatment, liver tissues were analyzed using quantitative real-time PCR (qPCR) to assess CYP2D6 mRNA expression. To determine PCR efficiency, a serial dilution of a known template was performed, and linear regression was carried out by plotting quantification cycle (Cq or Ct) values against the logarithm of template concentrations. Amplification curves confirmed successful CYP2D6 and β-Actin amplification (β-Actin Ct: 23-24; CYP2D6 Ct: 27-28). Both treatment groups showed a similar 1.7-fold increase in CYP2D6 expression relative to control (1.70 ± 0.06 for the 4 mg/kg group and 1.70 ± 0.03 for the 12 mg/kg group, versus 1.00 ± 0.11 in controls). No inferential statistical comparison between groups was performed given the small number of biological replicates, so this similarity is reported descriptively rather than as a statistically tested finding. These preliminary observations may be consistent with a stable expression pattern, potentially reflecting enzymatic saturation or species-specific regulatory mechanisms, although these mechanisms were not directly investigated in this study. Unlike humans, where CYP2D6 activity is highly polymorphic and dose-sensitive, Sahel goats may exhibit a more uniform metabolic response to tramadol. In conclusion, this preliminary study suggests possible differences in CYP2D6 regulation between goats, humans, and rodents, though confirmation in larger, adequately powered studies is needed. These findings emphasize the need to develop species-specific dosing guidelines rather than extrapolating from human models, and contribute preliminary data to veterinary pharmacogenomics that may guide further research on transcriptional regulation and metabolic adaptation in goats under chronic drug exposure.

Zitieren

APA

Gwiokura, A. Y., Adawaren, E. O., Lekko, Y. M., Mustapha, M., & Ngulde, S. I. (2026). Evaluation of CYP2D gene expression in Sahel goats under chronic tramadol exposure. Applied Veterinary Research, 5(3), 2026008. https://doi.org/10.31893/avr.2026008

Vancouver

Gwiokura AY, Adawaren EO, Lekko YM, Mustapha M, Ngulde SI. Evaluation of CYP2D gene expression in Sahel goats under chronic tramadol exposure. Applied Veterinary Research. 2026;5(3):2026008. doi:10.31893/avr.2026008

BibTeX
@article{Gwiokura2026,
  author = {Gwiokura, Aliyu Yahaya and Adawaren, Emmanuel O. and Lekko, Yusuf Madaki and Mustapha, Muhammad and Ngulde, Saidu Ibrahim},
  title = {Evaluation of CYP2D gene expression in Sahel goats under chronic tramadol exposure},
  journal = {Applied Veterinary Research},
  year = {2026},
  volume = {5},
  number = {3},
  pages = {2026008},
  doi = {10.31893/avr.2026008}
}
Kostenlos starten →